(
(51)InternationalPatentClassification:
A61K36/9066(2006.01)A61K31/12(2006.01)A23L33/10(2016.01)A61K31/715(2006.01)(21)InternationalApplicationNumber:
(74)Agent:CHALVIRE,Stanley,F.;Morse,Barnes-brown&
Pendleton,P.C.,Citypoint,230ThirdAvenue,4thFloor,Waltham,MA02451(US).(81)DesignatedStates(unlessotherwiseindicated,forevery
kindofnationalprotectionavailable).AE,AG,AL,AM,AO,AT,AU,AZ,BA,BB,BG,BH,BN,BR,BW,BY,BZ,CA,CH,CL,CN,CO,CR,CU,CZ,DE,DJ,DK,DM,DO,DZ,EC,EE,EG,ES,FI,GB,GD,GE,GH,GM,GT,HN,HR,HU,ID,IL,IN,IR,IS,JO,JP,KE,KG,KH,KN,KP,KR,KW,KZ,LA,LC,LK,LR,LS,LU,LY,MA,MD,ME,MG,MK,MN,MW,MX,MY,MZ,NA,NG,NI,NO,NZ,OM,PA,PE,PG,PH,PL,PT,QA,RO,RS,RU,RW,SA,SC,SD,SE,SG,SK,SL,SM,ST,SV,SY,TH,TJ,TM,TN,TR,TT,TZ,UA,UG,US,UZ,VC,VN,ZA,ZM,ZW.(84)DesignatedStates(unlessotherwiseindicated,forevery
kindofregionalprotectionavailable).ARIPO(BW,GH,GM,KE,LR,LS,MW,MZ,NA,RW,SD,SL,ST,SZ,TZ,UG,ZM,ZW),Eurasian(AM,AZ,BY,KG,KZ,RU,TJ,TM),European(AL,AT,BE,BG,CH,CY,CZ,DE,DK,EE,ES,FI,FR,GB,GR,HR,HU,IE,IS,IT,LT,LU,LV,MC,MK,MT,NL,NO,PL,PT,RO,RS,SE,SI,SK,SM,
PCT/US2019/025465
(22)InternationalFilingDate:
02April2019(02.04.2019)
(25)FilingLanguage:(26)PublicationLanguage:(30)PriorityData:
62/651,683
EnglishEnglish
US
02April2018(02.04.2018)
(71)Applicant:AVETABIOMICS,INC.[US/US];110Great
Road,Suite302,Bedford,MA01730(US).(72)Inventors:MEHTA,Parag,G.;4DublinCir,Burling?
ton,MAO1803(US).MUDGAL,Shamila;18ChadbourneRd,Lexington,MA02421(US).HINGORANI,Lai;31ParkWest,6UnionPark,Khar(west)Mumbai,Maharash?tra400052(IN).AVILA,Luis,Z.;11SleepyHollowLn,Arlington,MA02474(US).
(54)Title:POLYPHARMACEUTICALDRUGCOMPOSITIONSANDRELATEDMETHODS
Drug
substance
Drug
FIG.3
(57)Abstract:Disclosedarecompositionsandmethodsfortreatingoramelioratingthesymptomsofcancer(e.g.,oralcancer)byusingapoly-pharmaceuticaldrug,whosecompositionconsistsofrelationallyoptimizedratiosofbioactivecompoundstoenhancetheirpharmacologicalcharacteristics.
[Continuedonnextpage]
||||||||||||||||||||||11|||||||||||||||||||||||||||||||||limnnilnilnil
WO2019195349A1复方药物组合物和相关方法[专利] - 图文
